Lymphoma: Dual-Targeting CAR T Shows Safety, Efficacy ...Middle East

KITE-363, a dual-targeting CAR T-cell therapy, shows a strong safety profile and high responses in patients who have highly refractory large B-cell lymphoma, new research shows. Medscape Medical News

Hence then, the article about lymphoma dual targeting car t shows safety efficacy was published today ( Friday 13/06/2025 - 03:48 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Lymphoma: Dual-Targeting CAR T Shows Safety, Efficacy )

Also on site :

• ‘We can insure the ship, but we cannot insure a human life.’
• Israel’s military posted two images of Ali Choeib in what it said was a Hezbollah uniform. One was fake.
• Nelly Furtado Is More Gorgeous Than Ever 5 Months After Sharing She Quit Performing Due to Body Shaming